XML 45 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock Options
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Stock Options

10. Stock Options

 

In March 2023, the Company’s Board of Directors and stockholders approved the 2023 Stock Incentive Plan (“2023 Plan”). The 2023 Plan allows the Committee to grant up to 2,000,000 shares of Common Stock in the form of incentive and non-statutory stock options, restricted stock awards, restricted stock units, and other stock-based awards to employees, directors, and non-employees. As of December 31, 2023, options to purchase 40,000 shares of common stock had been granted and were outstanding under the 2023 Plan and 1,960,000 shares of common stock were available for grant under the plan.

 

During 2016, the Company established the Azitra Inc. 2016 Stock Incentive Plan (the Plan) which provides for the granting of stock options and restricted shares to the Company’s employees, officers, directors, advisors and consultants. As of December 31, 2023, options to purchase 1,248,255 shares of common stock had been granted and were outstanding under the 2016 Plan and 242,340 shares of common stock were available for grant under the plan.

 

During the year ended December 31, 2023, the Company recognized stock compensation expense of $125,555 and $25,950, included in general and administrative and research and development on the accompanying statement of operations, respectively. During the year ended December 31, 2022, the Company recognized stock compensation expense of $131,185 and $53,280, included in general and administrative and research and development on the accompanying statement of operations, respectively, relating to the issuance of service-based stock options. At December 31, 2023, there was $326,438 of unamortized compensation expense that will be amortized over a remaining weighted-average period for the 2016 Plan and 2023 Plan of approximately 1.32 and 3.58 years, respectively. At December 31, 2023 and 2022, there were 13,120 performance-based options outstanding with a fair value of $109,551. During the years ended December 31, 2023 and 2022, the Company did not recognize any compensation expense for performance-based options. The Company determined the options qualified as plain vanilla under the provisions of SAB 107 and the simplified method was used to estimate the expected option life.

 

The following table summarizes information about options outstanding and exercisable at December 31, 2023:

 

    Options Outstanding   Options Exercisable 
Exercise Price   Number of Options at December 31, 2023   Weighted Average Remaining Contractual Life   Weight Average Exercise Price   Number of Options at December 31, 2023   Weighted Average Remaining Contractual Life   Weighted Average Exercise Price 
$0.48    246,137    2.0 years   $0.48    246,137    2.0 years   $0.48 
$0.93    202,040    2.0 years   $0.93    202,036    2.0 years   $0.93 
$1.70    800,078    7.3 years   $1.70    572,968    7.0 years   $1.70 
$2.07    40,000    9.7 years   $2.07    4,167    9.7 years   $2.07 
      1,288,255              1,025,308           

 

Total stock option activity for the year ended December 31, 2023, is summarized as follows:

 

   Shares   Weighted Average Exercise Price 
Outstanding at December 31, 2021   1,381,908   $1.34 
Exercised   (888)   1.70 
Forfeited   (90,702)   5.91 
Outstanding at December 31, 2022   1,290,318   $1.33 
Granted   40,000    2.07 
Exercised        
Forfeited   (42,063)   0.87 
Outstanding at December 31, 2023   1,288,255   $1.37 

 

 

AZITRA, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

For the Years Ended December 31, 2023 and 2022

 

10. Stock Options (continued)

 

There are 242,340 shares available for future grant under the 2016 Plan and 1,960,000 available under the 2023 Plan at December 31, 2023.

 

Total intrinsic value for the 2016 plan for the year ended December 31, 2023, is summarized as follows:

 

   Options Outstanding at December 31, 2023   Options Exercisable at December 31, 2023 
Value of Stock at December 31, 2023  $0.92   $0.92 
Exercise Price   0.48    0.48 
Intrinsic Value Per Share   0.44    0.44 
Options O/S   246,137    246,137 
Intrinsic Value at December 31, 2023  $108,300   $108,300